Section Arrow
Quote
AXGN.NASDAQ
- Axogen
Quotes are at least 15-min delayed:2026/03/09 15:40 EDT
Regular Hours
Last
 29.31
+0.79 (+2.77%)
Day High 
29.49 
Prev. Close
28.52 
1-M High
35.89 
Volume 
487.61K 
Bid
29.25
Ask
29.39
Day Low
27.54 
Open
28.36 
1-M Low
28.19 
Market Cap 
1.43B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 31.01 
20-SMA 32.67 
50-SMA 32.8 
52-W High 35.9999 
52-W Low 9.215 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.34/0.83
Enterprise Value
1.50B
Balance Sheet
Book Value Per Share
2.48
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
225.21M
Operating Revenue Per Share
3.03
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.52+2.96+2.70%29.21PE
MDTMedtronic plc91.245+0.345+0.38%25.39PE
BSXBoston Scientific Corp72.155+0.805+1.13%36.78PE
BFLYButterfly Network3.8001+0.1501+4.11%-- 
PACBPacific Biosciences of California1.375-0.005-0.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health careproviders. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.